Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Connective Tissue Disorders
Your connective tissue supports many different parts of your body, such as your skin, eyes, and heart. It is like a "cellular glue" that gives your body parts their shape and helps keep them strong. It also helps some of your tissues do their work. It is made of many kinds of proteins. Cartilage and fat are types of connective tissue.
Over 200 disorders that impact connective tissue. There are different types:
- Genetic disorders, such as Ehlers-Danlos syndrome, Marfan syndrome, and osteogenesis imperfecta
- Autoimmune disorders, such as lupus and scleroderma
- Cancers, like some types of soft tissue sarcoma
Each disorder has its own symptoms and needs different treatment.
It sits within Bones, Joints and Muscles.
The lead U.S. institute for this subject is the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Connective Tissue Disorders
39,129 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)National Cancer Institute (NCI)
- Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryNational Cancer Institute (NCI)
- A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesAmgen
- Comparison of Postoperative Analgesic Efficacy of Two Different Blocks in Modified Radical Mastectomy SurgerySultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceNovartis Pharmaceuticals
- Deciphering the Genetic Architecture of Autoimmune DiseasesNational Human Genome Research Institute (NHGRI)
Research already completed
- Tumor-Derived FGF19University of Central Florida
- Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After SurgeryUniversity of Nebraska
- African Cancer Genome: GMDFox Chase Cancer Center
- NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid TumorsNational Cancer Institute (NCI)
- Dietary Salt in Rheumatoid ArthritisVanderbilt University Medical Center
- A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisTakeda
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Diagnosis and Tests
- ANA (Antinuclear Antibody) TestNational Library of Medicine
- Autoantibody TestingNational Library of Medicine
Genetics
- Achondrogenesis: MedlinePlus GeneticsNational Library of Medicine
- Arterial tortuosity syndrome: MedlinePlus GeneticsNational Library of Medicine
- Buschke-Ollendorff syndrome: MedlinePlus GeneticsNational Library of Medicine
- Congenital contractural arachnodactyly: MedlinePlus GeneticsNational Library of Medicine
- Cutis laxa: MedlinePlus GeneticsNational Library of Medicine
- Czech dysplasia: MedlinePlus GeneticsNational Library of Medicine
- Hyaline fibromatosis syndrome: MedlinePlus GeneticsNational Library of Medicine
- Hypochondrogenesis: MedlinePlus GeneticsNational Library of Medicine
- Kniest dysplasia: MedlinePlus GeneticsNational Library of Medicine
- Lateral meningocele syndrome: MedlinePlus GeneticsNational Library of Medicine
- Loeys-Dietz syndrome: MedlinePlus GeneticsNational Library of Medicine
- Otospondylomegaepiphyseal dysplasia: MedlinePlus GeneticsNational Library of Medicine
- Platyspondylic lethal skeletal dysplasia, Torrance type: MedlinePlus GeneticsNational Library of Medicine
- Pseudoxanthoma elasticum: MedlinePlus GeneticsNational Library of Medicine
- Shprintzen-Goldberg syndrome: MedlinePlus GeneticsNational Library of Medicine
- Spondyloepimetaphyseal dysplasia, Strudwick type: MedlinePlus GeneticsNational Library of Medicine
- Spondyloepiphyseal dysplasia congenita: MedlinePlus GeneticsNational Library of Medicine
- Spondyloperipheral dysplasia: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Connective Tissue Disorders: Recognizing and Treating Structural DefectsNational Institutes of Health
Clinical Trials
- ClinicalTrials.gov: Connective Tissue DiseasesNational Institutes of Health
- ClinicalTrials.gov: Mixed Connective Tissue DiseaseNational Institutes of Health
- ClinicalTrials.gov: Pseudoxanthoma ElasticumNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Connective Tissue Diseases. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Connective Tissue Disorders, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.